| 11169 |
13(R),14(R)-epoxy Fluprostenol isopropyl ester
New
|
|
- |
≥95%
|
|
|
2012-01-24
|
19.472990676394
|
13-r-14-r-epoxy-fluprostenol-isopropyl-ester
|
13(R),14(R)-epoxy Travoprost
|
travoprosts FP receptors agonists ocular hypotensive agents glaucoma impurity prostaglandins PGs prodrugs chiral enantiomer epoxide |
19.472990676394
|
| 11170 |
13(S),14(S)-epoxy Fluprostenol isopropyl ester
New
|
|
- |
≥95%
|
|
|
2012-01-24
|
20.009576042248
|
13-s-14-s-epoxy-fluprostenol-isopropyl-ester
|
13(S),14(S)-epoxy Travoprost
|
travoprost FP receptors agonists ocular hypotensive agents glaucoma impurity prostaglandins PGs prodrugs chiral enantiomers |
20.009576042248
|
| 10010405 |
15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide
|
|
- |
>98%
|
|
|
2008-01-10
|
22.252278193045
|
15-keto-17-phenyl-trinor-prostaglandin-f2-ethyl-amide
|
15-keto-Bimatoprost; 17-phenyl trinor PGF2α ethyl amide
|
17 phenyl trinor prostaglandins PGs ethyl amide intraocular hypotensive PGF2.alpha. IOP pressure glaucoma |
22.252278193045
|
| 16816 |
15-keto Latanoprost
|
|
- |
>98%
|
|
|
|
146.030230202577
|
15-keto-latanoprost
|
|
eyes ophthalmology ophthalmological intraocular glaucoma esters FP receptors agonists IOP pressure prostaglandins hypotensive |
146.030230202577
|
| 10010809 |
16-phenoxy tetranor Prostaglandin F2α cyclopropyl methyl amide
Exclusive
|
|
- |
≥98%
|
|
✓ |
2009-10-12
|
0E-12
|
16-phenoxy-tetranor-prostaglandin-f2-cyclopropyl-methyl-amide
|
16-phenoxy tetranor PGF2α cyclopropyl methyl amide
|
FPs receptors PGF2α PGs intraocular pressure IOPs |
0E-12
|
| 10010103 |
16-phenoxy tetranor Prostaglandin F2α isopropyl ester
Exclusive
|
|
130209-78-8 |
>95%
|
|
✓ |
2011-01-26
|
3.954874155923
|
16-phenoxy-tetranor-prostaglandin-f2-isopropyl-ester
|
16-phenoxy tetranor PGF2α isopropyl ester
|
prostaglandins F2a F2alpha F2.alpha. F2-a F2-alpha F2-.alpha. F2α F2-α PGF2α FP receptors PGs analogs glaucoma luteolysis reproductive biology intraocular pressure IOP |
3.954874155923
|
| 10010562 |
16-phenoxy tetranor Prostaglandin F2α methyl amide
|
|
- |
≥98%
|
|
|
2011-01-24
|
0E-12
|
16-phenoxy-tetranor-prostaglandin-f2-methyl-amide
|
16-phenoxy tetranor PGF2α methyl amide
|
prostaglandins F2α PGF2α FP receptors analogs glaucoma luteolysis reproductive biology intraocular pressure IOP PGs |
0E-12
|
| 10010102 |
16-phenoxy tetranor Prostaglandin F2α methyl ester
Exclusive
|
|
51638-90-5 |
>98%
|
|
✓ |
2010-12-06
|
8.481005524861
|
16-phenoxy-tetranor-prostaglandin-f2-methyl-ester
|
16-phenoxy tetranor PGF2α
|
prostaglandins PGS PGF2α PGF2a PGF2.alpha. PGF2alpha FP receptors analogs glaucoma luteolysis reproductive biology intraocular pressures IOP |
8.481005524861
|
| 10010460 |
17-chlorophenyl trinor Prostaglandin F2α ethyl amide
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-11-29
|
8.938784530386
|
17-chlorophenyl-trinor-prostaglandin-f2-ethyl-amide
|
17-chlorophenyl trinor PGF2α ethyl amide; Chlorophenyl Bimatoprost
|
luteolysis FP receptors EP1 intraocular pressures IOP glaucomas ophthalmology opthamology |
8.938784530386
|
| 10010839 |
17-phenoxy trinor Prostaglandin F2α
|
|
- |
>98%
|
|
|
2008-02-04
|
2.405237569060
|
17-phenoxy-trinor-prostaglandin-f2
|
17-phenoxy trinor PGF2α
|
PGF2a PGF2.alpha. PGs analogs tetranors FPs receptors luteal IOP glaucoma |
2.405237569060
|
| 10010742 |
17-phenoxy trinor Prostaglandin F2α ethyl amide
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-11-29
|
14.922511300853
|
17-phenoxy-trinor-prostaglandin-f2-ethyl-amide
|
17-phenoxy trinor PGF2α ethyl amide
|
prostaglandins F2α PGF2α FP receptors smooth muscles contractions luteolysis IOP glaucoma PGs |
14.922511300853
|
| 10010723 |
17-phenoxy trinor Prostaglandin F2α isopropyl ester
Exclusive
|
|
- |
≥98%
|
|
✓ |
2009-04-15
|
30.424287292817
|
17-phenoxy-trinor-prostaglandin-f2-isopropyl-ester
|
17-phenoxy-PGF2α isopropyl ester
|
FP receptors analogs intraocular pressure IOP FPs PGF2α |
30.424287292817
|
| 16810 |
17-phenyl trinor Prostaglandin F2α
Exclusive
|
|
38344-08-0 |
>98%
|
|
✓ |
|
60.571522940187
|
17-phenyl-trinor-prostaglandin-f2
|
17-phenyl trinor PGF2α; Bimatoprost (free acid)
|
analogs agonists FP receptors 17-phenyl-trinor-PGF2.alpha. 17-phenyl-trinor-PGF2alpha prostaglandins intraocular pressure iop |
60.571522940187
|
| 9000686 |
17-phenyl trinor Prostaglandin F2α cyclohexyl amide
Exclusive
|
|
- |
≥95%
|
|
✓ |
2010-10-11
|
34.636896869244
|
17-phenyl-trinor-prostaglandin-f2-cyclohexyl-amide
|
Bimatoprost cyclohexyl amide
|
agonists FP receptors glaucoma intraocular pressure luteolysis parturition prostaglandins PGs |
34.636896869244
|
| 10010605 |
17-phenyl trinor Prostaglandin F2α cyclopropyl amide
Exclusive
|
|
- |
≥95%
|
|
✓ |
2009-05-08
|
12.350900552486
|
17-phenyl-trinor-prostaglandin-f2-cyclopropyl-amide
|
17-phenyl trinor PGF2α cyclopropyl amide; Bimatoprost cyclopropyl amide
|
PGF2α FP glaucoma ocular hypertension prostaglandins amides cycoprepylamides novel analogs |
12.350900552486
|
| 10010810 |
17-phenyl trinor Prostaglandin F2α cyclopropyl methyl amide
Exclusive
|
|
1138395-10-4 |
≥98%
|
|
✓ |
2011-01-25
|
17.882854511970
|
17-phenyl-trinor-prostaglandin-f2-cyclopropyl-methyl-amide
|
17-phenyl trinor PGF2α cyclopropyl methyl amide
|
prostaglandins F2α PGF2α FP receptors luteolysis analogs bimatoprosts glaucoma intraocular pressure IOP PGs |
17.882854511970
|
| 16823 |
17-phenyl trinor Prostaglandin F2α diethyl amide
|
|
- |
>98%
|
|
|
|
12.350900552486
|
17-phenyl-trinor-prostaglandin-f2-diethyl-amide
|
17-p-PGF2α-NEt2; 17-phenyl trinor PGF2α diethyl amide; Bimatoprost diethyl amide
|
eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids hypotensive IOP pressure 17-phenyl-trinor-PGF2.alpha.-NEt2 17-phenyl-trinor-PGF2alpha-NEt2 17-p-PGF2.alpha.-NEt2 17-p-PGF2alpha-NEt2 17-p-PGF2a-NEt2 N-ethyl amides |
12.350900552486
|
| 516821 |
17-phenyl trinor Prostaglandin F2α EIA Kit
|
|
- |
|
|
|
|
52.853671521848
|
17-phenyl-trinor-prostaglandin-f2-eia-kit
|
Bimatoprost (fee acid) ELISA Kit
|
solid plates 17-phenyl-trinor-PGF2alpha prostaglandins 17-phenyl-trinor-PGF2.alpha. measures kits eias enzyme immunoassays ELISAs EIA assays |
52.853671521848
|
| 16820 |
17-phenyl trinor Prostaglandin F2α ethyl amide
|
|
155206-00-1 |
>97%
|
|
|
|
35.135654410364
|
17-phenyl-trinor-prostaglandin-f2-ethyl-amide
|
17-phenyl trinor PGF2α ethyl amide; Bimatoprost; 15(S)-Bimatoprost
|
lumigan prostaglandins N-ethylamides intraocular hypotensive agonists IOP glaucoma 17-phenyl-trinor-pgf2alpha-ethylamide 17-phenyl-trinor-pgf2a-ethylamide 17-phenyl-trinor-pgf2.alpha.-ethylamide FP receptors ophthalmology |
35.135654410364
|
| 16824 |
17-phenyl trinor Prostaglandin F2α isopropyl ester
|
|
130209-76-6 |
>98%
|
|
|
|
133.014113897152
|
17-phenyl-trinor-prostaglandin-f2-isopropyl-ester
|
17-phenyl trinor PGF2α isopropyl ester; 17-phenyl trinor PGF2α-iPr; Bimatoprost isopropyl ester
|
analogs esters eyes intraocular hypotensive pressure lumigan bimatoprost 17-phenyl-trinor-PGF2.alpha.-iPr 17-phenyl-trinor-PGF2alpha-iPr 17-phenyl-trinor-PGF2a-iPr IOP prostaglandins ophthalmology glaucoma |
133.014113897152
|
| 10010110 |
17-phenyl trinor Prostaglandin F2α methyl ester
Exclusive
|
|
38315-47-8 |
≥98%
|
|
✓ |
2011-01-19
|
17.882854511970
|
17-phenyl-trinor-prostaglandin-f2-methyl-ester
|
Bimatoprost methyl ester; 17-phenyl trinor PGF2α methyl ester
|
prostaglandins F2α PGF2α FP receptors luteolysis analogs latanoprosts glaucoma intraocular pressure IOP PGs bimatoprost |
17.882854511970
|
| 10010061 |
17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide
|
|
- |
>98%
|
|
|
2010-12-06
|
201.180505130228
|
17-trifluoromethylphenyl-trinor-prostaglandin-f2-ethyl-amide
|
17-trifluoromethylphenyl trinor PGF2α ethyl amide
|
trifluoro methyl phenyl trinor PGF2α amides prostaglandins PGs FP receotirs travoprost latanoprost glaucoma luteolysis reproductive bilogy |
201.180505130228
|
| 10010062 |
17-trifluoromethylphenyl trinor Prostaglandin F2α isopropyl ester
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-12-13
|
0.046408839779
|
17-trifluoromethylphenyl-trinor-prostaglandin-f2-isopropyl-ester
|
17-trifluoromethylphenyl trinor PGF2α isopropyl ester
|
prostaglandins F2α PGF2α FP receptors travoprosts latanoprosts glaucoma luteolysis reproductive biology PGs IOP intraocular pressure |
0.046408839779
|
| 10010111 |
17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester
Exclusive
|
|
195503-20-9 |
≥98%
|
|
✓ |
2011-01-19
|
0.037127071823
|
17-trifluoromethylphenyl-trinor-prostaglandin-f2-methyl-ester
|
17-trifluoromethylphenyl trinor PGF2α methyl ester
|
prostaglandins F2α PGF2α FP receptors travoprosts latanoprosts glaucoma luteolysis reproductive biology PGs |
0.037127071823
|
| 90312 |
4,5-dehydro Docosahexaenoic Acid
|
|
- |
≥98%
|
|
|
|
25.332228360957
|
4-5-dehydro-docosahexaenoic-acid
|
4,5-dehydro Cervonic Acid; 4,5-dehydro DHA
|
w-3 fatty acids omega-3 .omega.-3 n-3 analogs acetylene 5-LO 5-lipoxygenases inhibits inhibitors |
25.332228360957
|
| 10129 |
5-trans Latanoprost (free acid)
|
|
903549-49-5 |
>98%
|
|
|
2009-04-06
|
80.580285451196
|
5-trans-latanoprost-free-acid
|
5,6-trans Latanoprost (free acid)
|
isomers impurity intraocular pressure |
80.580285451196
|
| 10008436 |
8-iso-17-phenyl trinor Prostaglandin F2β
|
|
- |
>98%
|
|
|
2006-06-14
|
11.866187845303
|
8-iso-17-phenyl-trinor-prostaglandin-f2
|
|
Bimatoprost analogs prostaglandins PGF2alpha PGF2.alpha. PGF2beta PGF2.beta. agonists 17-phenyl-trinor FP receptors inhibits inibitors inhibition isomers ophthalmology glaucoma IOP intraocular pressure ophthalmology |
11.866187845303
|
| 13619 |
ACS 67
Exclusive
|
|
1088434-86-9 |
≥95%
|
|
✓ |
2010-01-19
|
87.007044623884
|
acs-67
|
|
IOPs glaucoma intra ocular pressures latanoprost (free acid) hydrogen sulfide free acids H2Ss hypotensive carboxyl group reduced glutathione cGMP cyclic GMP |
87.007044623884
|
| 10011546 |
AL 34662
|
|
210580-75-9 |
≥98%
|
|
|
2008-11-12
|
45.421248618784
|
al-34662
|
AL 34497
|
serotonins 5-HTs 5HT 5-hydroxy trptamine IOPs intraocular pressure glaucoma ophthalmology lower 5-hydroxytrptamine |
45.421248618784
|
| 13620 |
AL 6598
Exclusive
|
|
170291-06-2 |
97%
|
|
✓ |
2010-09-16
|
98.823082872928
|
al-6598
|
|
intraocular pressures IOPs glaucoma PGD2 agonists DP receptors eyes hypertension F2 alpha Prostaglandin
Prostaglandin F2 alpha
F2alpha Prostaglandin
Prostaglandin F2alpha
9alpha,11beta-PGF2
9alpha,11beta PGF2
Prostaglandin F2
Enzaprost F alpha, PGF2 PGF2 alpha PGF2alpha Dinoprost Estrofan PGF2 |
98.823082872928
|
| 10010470 |
AL 8810 ethyl amide
|
|
- |
>98%
|
|
|
2008-01-18
|
9.821657458563
|
al-8810-ethyl-amide
|
|
FP receptors PGF2.alpha. prostamides ethanolamides IOP glaucoma contraction iris |
9.821657458563
|
| 10008370 |
AL 8810 methyl ester
|
|
- |
>98%
|
|
|
2006-10-05
|
7.634198895027
|
al-8810-methyl-ester
|
|
FP antagonists prostaglandins PGFs receptors AL8810 AL-8810 PGF2alpha PGF2.alpha. analogs esters intraocular |
7.634198895027
|
| 10007955 |
CAY10498
|
|
863202-33-9 |
≥98%
|
|
|
2006-08-02
|
41.749779005525
|
cay10498
|
2-phenyl-amino-N6-endo-norbornyladenine
|
adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology |
41.749779005525
|
| 10562 |
CAY10631
Exclusive
|
|
- |
≥95%
|
|
✓ |
2011-02-10
|
0.281767955801
|
cay10631
|
|
Very long chain fatty acids docosahexaenoic elongases retinas macular diseases rhodopsin |
0.281767955801
|
| 10497 |
CAY10632
Exclusive
|
|
105517-82-6 |
≥98%
|
|
✓ |
2011-03-14
|
0.348066298342
|
cay10632
|
|
very long chain fatty acids VLCPUFA retinas macular diseases ELOVL4 dotriacontahexaenoic FA-4 FA4 retinal macular degeneration |
0.348066298342
|
| 10008027 |
cGMP Bimatoprost
GMP API
|
|
155206-00-1 |
|
|
|
2010-08-25
|
2409.088397790055
|
cgmp-bimatoprost
|
|
|
2409.088397790055
|
| 10011176 |
cGMP Latanoprost
GMP API
|
|
130209-82-4 |
|
|
|
2004-06-01
|
2878.121546961326
|
cgmp-latanoprost
|
|
|
2878.121546961326
|
| 30011 |
cGMP Travoprost
GMP API
|
|
157283-68-6 |
|
|
|
2008-12-08
|
1762.403314917127
|
cgmp-travoprost
|
(+)-16-m-trifluoromethylphenoxy tetranor Prostaglandin F2α isopropyl ester; (+)-Fluprostenol ispopropyl ester
|
|
1762.403314917127
|
| 580120 |
CTRP5 (human) EIA Kit
|
|
- |
|
|
|
2011-08-02
|
6.277106353591
|
ctrp5-human-eia-kit
|
C1QTNF; C1q tumor necrosis factor-α-related protein 5
|
C1q/tumors necrosis factors 5 superfamily genes untranslated membranes frizzled-related proteins MFRP bicistronic transcript mutations late-onset retinal degeneration LORD apical basal pigmented epithelium ciliary tissues neuroectodermal macular adipose blood glycoproteins trimers oligomeric complexes disulfide bonds N-terminal N-terminus cysteine residues extracellular recombinant activator adenosine monophosphates AMP-activated kinases AMPK cells GLUT4 glucose uptake serum obese diabetic mice mouse competitive plasma assays kits measures measurements EIAs ELISAs enzymes immunoassays |
6.277106353591
|
| 10349 |
Cytokeratin Monoclonal FITC Antibody (Clone C-11)
|
|
- |
|
|
|
2010-04-14
|
17.487668508287
|
cytokeratin-monoclonal-fitc-antibody-clone-c-11
|
pan-Cytokeratin
|
cytokeratins pan-cytokeratins antibodies antiserum antisera isoforms western blots WB flow cytometry FC immunofluorescence IF immunoblotting proteins blotting |
17.487668508287
|
| 10010978 |
Diphenylphosphine isopropyl ester
|
|
- |
≥98%
|
|
|
2008-02-07
|
123.445211786372
|
diphenylphosphine-isopropyl-ester
|
DPP isopropyl ester
|
latanoprost glaucoma IOP intraocular pressure impurity commercial preparations |
123.445211786372
|
| 16768 |
Fluprostenol
Exclusive
|
|
54276-17-4 |
≥95%
|
|
✓ |
|
77.438950276243
|
fluprostenol
|
16-m-trifluoromethylphenoxy tetranor PGF2α
|
16767 PGF2alpha PGF2.alpha. analogs FP agonists luteolysis prostaglandins receptors (+)-Fluprostenol |
77.438950276243
|
| 516761 |
Fluprostenol EIA Kit
|
|
- |
|
|
|
|
66.346850828728
|
fluprostenol-eia-kit
|
16-m-trifluoromethylphenoxy tetranor Prostaglandin F2α; Fluprostenol ELISA Kit
|
solid plates prostaglandins measures kits eias enzyme immunoassays ELISAs eyes ophthalmology ophthalmological intraocular glaucoma esters assays (+)-Fluprostenols 16-meta-trifluoromethylphenoxy |
66.346850828728
|
| 10010406 |
Fluprostenol methyl amide
Exclusive
|
|
- |
≥98%
|
|
✓ |
2009-04-17
|
6.230298992525
|
fluprostenol-methyl-amide
|
|
FPs PGF2α glaucoma ocular hypertension fluprostenol luteolysis |
6.230298992525
|
| 10010151 |
Fluprostenol methyl ester
|
|
73275-76-0 |
≥98%
|
|
|
2009-03-16
|
7.061005524861
|
fluprostenol-methyl-ester
|
|
FP PGF2.alpha. glaucoma ocular hypertension fluprostenol luteolysis hair growth |
7.061005524861
|
| 10004236 |
Fluprostenol serinol amide
|
|
- |
≥98%
|
|
|
2004-09-23
|
7.056596685083
|
fluprostenol-serinol-amide
|
Flu-SA
|
PGF2.alpha. PGF2alpha analogs agonists prostaglandins receptors amides cannabinoids CB1 CBs synthetic |
7.056596685083
|
| 9001148 |
Ketorolac
New
|
|
74103-06-3 |
≥98%
|
|
|
2012-01-12
|
12.447457304307
|
ketorolac
|
Sprix®; Acular PF®; RS 37619; Acular LS®
|
analgesic NSAIDs COX inhibition inhibits inhibitors ocular pain inflammation PGE2 non steroidal anti-inflammatory antiinflammatory drugs heteroaryl acetic acids derivatives cyclooxygenase opthalmalic solutions ocular COX-1 COX-2 COX1 COX2 racemic 66635-83-4 |
12.447457304307
|
| 16812 |
Latanoprost
|
|
130209-82-4 |
>98%
|
|
|
|
314.374212154695
|
latanoprost
|
CAY530500; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α isopropyl ester; 17-phenyl-13,14-dihydro trinor PGF2α isopropyl ester
|
eyes ophthalmology ophthalmological intraocular glaucoma esters FP receptors agonists IOP pressure prostaglandins 17-phenyl-13,14-dihydro-trinor-PGF2.alpha. 17-phenyl-13,14-dihydro-trinor-PGF2alpha |
314.374212154695
|
| 10006556 |
Latanoprost-d4
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
|
2005-11-30
|
37.020092081030
|
latanoprost-d4
|
17-phenyl-13,14-dihydro trinor Prostaglandin F2α-d4 isopropyl ester
|
eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 17-phenyl-13,14-dihydro-trinor-PGF2.alpha.-d4 17-phenyl-13,14-dihydro-trinor-PGF2alpha-d5 17-phenyl-13,14-dihydro trinor-PGF2a-d4 PGs |
37.020092081030
|
| 516811 |
Latanoprost EIA Kit
|
|
- |
|
|
|
|
153.818618784530
|
latanoprost-eia-kit
|
Latanoprost ELISA Kit; PhXA 85 EIA Kit; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α isopropyl ester EIA Kit; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α EIA Kit
|
solid plates prostaglandins measures kits eias enzyme immunoassays ELISAs eyes ophthalmology ophthalmological intraocular glaucoma esters FP receptors agonists phxa85 17-phenyl-13,14-dihydro-trinor-PGF2alpha 17-phenyl-13,14-dihydro-trinor-PGF2.alpha. assays |
153.818618784530
|
| 16811 |
Latanoprost (free acid)
|
|
41639-83-2 |
≥98%
|
|
|
|
97.537305972112
|
latanoprost-free-acid
|
PhXA-85; Lat-FA; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α
|
eyes glaucoma prostaglandins agonists FP receptors phxa85 ophthalmology ophthalmological intraocular acids 17-phenyl-13,14-dihydro-trinor-PGF2.alpha. PhXA85 17-phenyl-13,14-dihydro-trinor-PGF2alpha IOP |
97.537305972112
|
| 11435 |
Mitomycin C
New
|
|
50-07-7 |
≥98%
|
|
|
2012-04-19
|
76.146300654835
|
mitomycin-c
|
Mitonco; NSC 26980; Mitoplus; Ametycine; MMC; MitoExtra
|
mitocin C NSC-26980 NSC26980 7481-68-7 74349-48-7 144085-53-0 antitumor antibiotics alkylating agents DNA crosslinkers antiproliferative synthesis genetics recombination repair chemotherapy wounds healing glaucoma tumors NADH cytochromes Streptomyces caespitosus genes mutagenensis cornea ophthalomology mito-extra mutamycin mytomycin kyowa S |
76.146300654835
|
| 12990 |
Prostaglandin D3
Exclusive
|
|
71902-47-1 |
>98%
|
|
✓ |
|
72.632799263352
|
prostaglandin-d3
|
PGD3
|
PGD3 omega-3 w-3 .omega.-3 metabolites EPA eicoaspentaenoic acid prostaglandins |
72.632799263352
|
| 14990 |
Prostaglandin E3
Exclusive
|
|
802-31-3 |
>98%
|
|
✓ |
|
20.888370165746
|
prostaglandin-e3
|
PGE3
|
PGE3 omega-3 metabolites prostaglandins .omega.-3 w-3 intraocular pressure IOP COX cyclooxygenaes eyes |
20.888370165746
|
| 10928 |
SUCNR1 Polyclonal Antibody
|
|
- |
|
|
|
2011-11-03
|
0.904972375691
|
sucnr1-polyclonal-antibody
|
GPR91
|
membranes receptors G-proteins coupled 1 family cells communications citric acids cycles succinate developments injury angiogenic factors VEGF proliferative ischemic retinopathy diabetic Western blots blotting immunohistochemistry IHC WB SUCNR-1 SUCNRs |
0.904972375691
|
| 10005440 |
Tafluprost
|
|
209860-87-7 |
>98%
|
|
|
2004-10-05
|
112.540037390479
|
tafluprost
|
AFP-168
|
eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids 17-phenyl trinor-PGF2.alpha. 17-phenyl trinor-PGF2alpha 15-deoxy-15,15-difluoro PGF analogs 16-phenoxy hypotensive |
112.540037390479
|
| 9000843 |
Tafluprost ethyl amide
New
|
|
1185851-52-8 |
≥98%
|
|
|
2012-02-14
|
58.651647227337
|
tafluprost-ethyl-amide
|
|
glaucoma prostaglandins PGs agonists FP receptors ophthalmology 17-phenyl trinor-PGF2α PGF analogs hypotensive lipids tissues |
58.651647227337
|
| 11612 |
Tafluprost ethyl ester
Exclusive New
|
|
209860-89-9 |
≥98%
|
|
✓ |
2012-04-20
|
137.247943523633
|
tafluprost-ethyl-ester
|
AFP 175
|
AFP-175 AFP175 glaucoma intraocular pressure receptors agonists prostaglandins PGs analogs ophthalmology FP lipids tissues |
137.247943523633
|
| 10005439 |
Tafluprost (free acid)
|
|
209860-88-8 |
>98%
|
|
|
2004-09-22
|
87.907304218188
|
tafluprost-free-acid
|
AFP-172
|
eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular AFP172 hypotensives pressure IOP |
87.907304218188
|
| 10007207 |
tetranor-12(S)-HETE
|
|
121842-79-3 |
≥98%
|
|
|
2005-12-07
|
29.745690607734
|
tetranor-12-s-hete
|
|
neuroscience peroxisomes metabolites arachidonic acids metabolisms 12-lipoxygenases 12-LOs platelets leukocytes smooth muscle cells tumors adhesion endothelial fibronectin subendothelial matrix b-oxidation .beta.-oxidation tissues Lewis lung carcinomas controlling inflammations inflammatory responses injured corneas Zellweger's syndromes peroxisomal abnormalities inability metabolizes symptoms diseases derivatives reasearch tools elucidations metabolic fate cancers ophthalmology |
29.745690607734
|
| 10010421 |
Zaprinast
|
|
37762-06-4 |
≥98%
|
|
|
2008-09-18
|
6.124180478821
|
zaprinast
|
2-(o-Propoxyphenyl)-8-azapurin-6-one; M&B 22,948
|
sildenafil viagra phophodiesterase cGMP PDE5 GRP35 inhibitors inhibits inhibition M&B 22948 55122-20-8 |
6.124180478821
|
| 10009992 |
Zeaxanthin
|
|
144-68-3 |
≥98%
|
|
|
2009-02-02
|
19.107532228360
|
zeaxanthin
|
Zeaxanthol; Xanthophyll 3; Anchovyxanthin
|
carotenoid degeneration AMDs luteins diabetes antioxidant oxidative injury injuries VEGFs macula |
19.107532228360
|
| 13673 |
ZK118182 isopropyl ester
Exclusive
|
|
154927-31-8 |
≥98%
|
|
✓ |
2010-11-05
|
0.845303867403
|
zk118182-isopropyl-ester
|
|
intraocular pressure IOP glaucoma PGD2 agonists DP receptors hypertension Hexadecanoylcarnitine
Palmitoylcarnitine
Palmitylcarnitine |
0.845303867403
|
| 16837 |
β-Carotene
|
|
7235-40-7 |
≥95%
|
|
|
2010-08-20
|
11.627458563535
|
-carotene
|
KPMK; Lucarotin; Provatene; Solatene; Food Orange 5; Provitamin A; NSC 62794
|
vitamins A antioxidant retinol retinoic acids vision bone growth receptors RAR cell differentiation 116-32-5 31797-85-0 lucaratin lurotin provatenol serlabo βCarotene β Carotene b-carotene carotaben b bcarotene retinol |
11.627458563535
|